Figure 16).
Theoretical impact of early treatment with single-inhaler budesonide/formoterol maintenance and reliever therapy (SMART) or fixed-dose inhaled corticosteroids/long-acting beta-2 agonist combination therapy on the occurrence of exacerbations or further asthma worsenings